What is the recommended screening interval for a 33-year-old female with a negative Pap (Papanicolau) smear and negative Human Papillomavirus (HPV) test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cervical Cancer Screening Interval for a 33-Year-Old Female with Negative Pap and HPV Tests

For a 33-year-old woman with both negative Pap smear and negative HPV test results, the recommended screening interval is 5 years.

Rationale for 5-Year Screening Interval

The American Cancer Society (ACS) and US Preventive Services Task Force (USPSTF) guidelines clearly recommend a 5-year screening interval for women aged 30-65 years who have negative results on both Pap smear and HPV testing (co-testing) 1, 2.

This recommendation is based on:

  • The high negative predictive value of co-testing, which provides greater reassurance against cervical cancer than either test alone
  • Evidence showing the risk of developing cervical intraepithelial neoplasia grade 3 or worse (CIN3+) is extremely low after a negative co-test result
  • Studies demonstrating the safety of extended screening intervals in this population 3, 4

Important Distinctions in Screening Recommendations

It's important to note the difference between various screening scenarios:

  • Co-testing (Pap + HPV) negative: 5-year interval (applies to this case)
  • Pap test alone negative: 3-year interval
  • HPV-negative ASC-US: 3-year interval (not 5 years) 5

The ACS specifically states: "For women aged 30 to 65 years, the preferred approach is cotesting every 5 years with cytology and HPV testing" 5. This is the scenario that applies to our 33-year-old patient with both negative Pap and HPV tests.

Clinical Implementation Considerations

Despite clear guidelines supporting 5-year intervals after negative co-testing, research shows many physicians continue to recommend more frequent screening. A study found that only 19% of primary care physicians would wait 3 years for the next Pap test after a normal Pap and negative HPV test 6.

This represents potential overscreening, which can lead to:

  • Unnecessary procedures
  • Patient anxiety
  • Increased healthcare costs
  • Potential harms from false positive results

Special Considerations

This recommendation applies to women at average risk. Women with the following conditions require different screening approaches:

  • History of cervical cancer
  • In utero DES exposure
  • Immunocompromised status (including HIV)
  • Previous high-grade precancerous lesions

Conclusion

Based on the most current guidelines from major organizations, a 33-year-old woman with negative results on both Pap smear and HPV testing should return for her next cervical cancer screening in 5 years 5, 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.